Digital Health Accelerators Digital Health Today Ambassadors Digital Health Today Podcast Digital Health Today-Resources Digital Health Today Ambassadors

Digital Health Today 360°

S10: #095: From DOCSF/JPM: Daniel Kraft reflects on 2019 and transformative ideas for the decade ahead

In this episode, we talk about Digital.Health, avatars, chatbots, drones, and more
January 28, 2020
S10: #095: From DOCSF/JPM: Daniel Kraft reflects on 2019 and transformative ideas for the decade ahead
Advertisement

The DOCSF meeting is a great way to get geared up before #JPM Week in San Francisco. Now in its fourth year, the Digital Orthopedics Conference, San Francisco, is organized by Prof Stefano Bini and Shawna Butler. This year, the sessions featured leaders from Microsoft, Google, Mozilla, Amazon and many other amazing organizations, and I interviewed some of the speakers following their sessions on the stage. This special series of episodes features some of the interviews recorded at this annual event. To hear all the sessions on the DOCSF podcast, be sure to subscribe to the DOCSF Podcast here.

Our guest:

In this episode, I spoke to Dr. Daniel Kraft. Daniel is a Stanford and Harvard trained physician-scientist, inventor, entrepreneur, and innovator. With over 25 years of experience in clinical practice, biomedical research and healthcare innovation, Kraft has chaired the Medicine for Singularity University since its inception in 2008. He is also founder and chair of Exponential Medicine (next being held November 9-12, 2020), a program that explores convergent, rapidly developing technologies and their potential in biomedicine and healthcare.

Links and Resources:

Daniel Kraft on 

LinkedIn  

Personal Website  

NEW! Digital.Health Website

Exponential Medicine  

Website 

Twitter 

Digital Health Today is made possible by the support of our sponsors. Thank you!

Learn more about your ad choices. Visit megaphone.fm/adchoices

cover
Coffee Talk: How Corporations Adapt in the Face of New Challenges Innovating at the speed of COVID-19. PLUS: Meet the new companies in the 2020 cohort of Bayer G4A
X
X